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ABSTRACT
The archaeal/eukaryotic proliferating cell nuclear
antigen (PCNA) toroidal clamp interacts with a host
of DNA modifying enzymes, providing a stable
anchorage and enhancing their respective proces-
sivities. Given the broad range of enzymes with
which PCNA has been shown to interact, relatively
little is known about the mode of assembly of func-
tionally meaningful combinations of enzymes on the
PCNA clamp. We have determined the X-ray crystal
structure of the Sulfolobus solfataricus PCNA1–
PCNA2 heterodimer, bound to a single copy of
the flap endonuclease FEN1 at 2.9 A˚ resolution. We
demonstrate the specificity of interaction of the
PCNA subunits to form the PCNA1–PCNA2–PCNA3
heterotrimer, as well as providing a rationale for
the specific interaction of the C-terminal PIP-box
motif of FEN1 for the PCNA1 subunit. The structure
explains the specificity of the individual archaeal
PCNA subunits for selected repair enzyme ‘clients’,
and provides insights into the co-ordinated
assembly of sequential enzymatic steps in PCNA-
scaffolded DNA repair cascades.
INTRODUCTION
DNA-binding processivity factors, such as the prokaryotic
b-clamp and the archaeal/eukaryotic proliferating cell nuclear
antigen (PCNA) provide stable anchorages on DNA for DNA
modifying enzymes, whose functional mechanistic inter-
action with DNA is inherently transient (1). These toroidal
structures are loaded onto DNA, encircling it to act as a
sliding clamp and vastly increasing the processivity of
attached enzymes (2).
In addition to replicative DNA polymerases, PCNA and
its homologues have been shown to interact with a broad
range of DNA modifying enzymes implicated in such DNA
metabolic processes as DNA replication, Okazaki fragment
maturation, DNA methylation, nucleotide excision repair
(NER), mismatch repair (MMR) and long-patch base excision
repair (LP-BER). In general, the principal interaction is
mediated by recognition of a PCNA-interacting protein
motif (PIP-box) of the ‘client’ enzyme, which binds the inter-
domain connector loop (IDCL) of a PCNA subunit (3).
Examples of client DNA repair enzymes include: DNA
glycosylases, such as MYH (4) NTH1 (5) and UNG (6);
nucleases, such as FEN1 (7), APE1 (8) and APE2 (9), as
well as DNA ligase I (10).
The multiple equivalent binding sites presented by an oli-
gomeric toroidal clamp and the large number of possible
PCNA clients that could be recruited, raises the question as
to how assembly of functionally ‘meaningful’ combinations
of clamp-bound enzymes is regulated. For example, a com-
bination of PCNA-bound Pol d, FEN1 and DNA Ligase 1
can restore a DNA strand following base excision by a glyco-
sylase and AP-endonuclease, by extending the 30 side of the
gap, excising the displaced 50-flap, and ligating the nick (7).
However, a combination of PCNA-bound DNA glycosylases,
UNG, MYH and NTH1, or PCNA loaded with three copies
of FEN1 would be ineffectual. Furthermore, as reaction
pathways of this type may potentially require a sequential
‘hand-off’ of intermediate products from one enzyme to
the next (11), the correct order of enzymes around the ring
also becomes important. Clearly some combinations may be
precluded by steric clashes between large proteins (e.g.
replicative polymerases), or favoured by evolved lateral con-
tacts between enzymes bound to adjacent PCNA subunits.
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However, structural studies of multiply loaded PCNA clamps
have not provided supportive evidence for this so far (12).
In organisms, which utilize a homotrimeric PCNA system,
the stoichiometry and composition of complexes with
adaptor proteins is in principle stochastic. Thus, all possible
productive and non-productive combinations of PCNA and
adaptors may compete for access to a DNA lesion or growth
point. However, the evolution of a heterotrimeric PCNA in
Sulfolobus solfataricus suggests there is a selective pressure
to favour meaningful combinations of adaptor/client proteins
on the PCNA clamp and provides a useful system to investi-
gate these specific adaptor protein interactions and molecular
assemblies. The hyperthermophilic acidophile archaeon
S.solfataricus contains three homologous but distinct PCNA
genes, whose products form a heterotrimeric clamp with a
defined composition and order of assembly. PCNA1 and
PCNA2 form a stable heterodimer, the generation of which
is a prerequisite for binding PCNA3 (13). Each subunit in
the active S.solfataricus PCNA heterotrimer displays pre-
ferential binding to a subset of client enzymes. Thus, the
archaeal FEN1 binds PCNA1, DNA Polymerase B1 binds
PCNA2, DNA Ligase 1 and UDG bind PCNA3, while XPF
binds PCNA1 and PCNA3 (13–15).
Here we report the 2.9 A˚ crystal structure of the
S.solfataricus PCNA1–PCNA2 heterodimer in complex
with FEN1. The PCNA1-2 heterodimer structure demon-
strates specificity and chirality for its own toroidal ring
assembly as demonstrated by the co-crystal structure,
modelling of the PCNA heterotrimer and mutational data.
In addition, the PCNA subunits demonstrate specificity for
the client proteins to which they bind through structural
differences between their inter-domain connecting-linker
(IDCL) segments.
MATERIALS AND METHODS
Protein expression and purification
Recombinant plasmid DNA coding for S.solfataricus
PCNA1, PCNA2, PCNA3 and FEN1 were subcloned into
pET11a (Novagen), pGEX-6P1 (GE Healthcare), pET30a
(Novagen) and pET33b (Novagen), respectively. All three
proteins were expressed separately in the Escherichia coli
ROSETTA (Novagen) BL21 (DE3) host strain for 20 h at
293 K with addition of 1 mM isopropyl-b-D-thiogalactoside
(IPTG).
PCNA1, PCNA2 and PCNA3 cell pellets were combined
and resuspended in buffer containing 20 mM Tris–HCl
(pH 7.5), 200 mM NaCl, 1 mM DTT supplemented with
complete EDTA-free protease inhibitors (Roche). The cells
were disrupted by sonication and the bacterial lysate clarified
by centrifugation at 48 384 g for 60 min using a Beckman
JA-20 rotar. Soluble cell lysate was then applied to Glutathione
Sepharose 4B (GST) resin (GE Healthcare) and extensively
washed in 20 mM Tris–HCl (pH 7.5), 200 mM NaCl and 1
mM DTT. The Glutathione Sepharose 4B resin was then
resuspended in 20 mM Tris–HCl, 50 mM NaCl and 1 mM
DTT, and incubated with PreScission Protease for 20 h at
277 K to remove the GST tag from PCNA2. The PCNA1–
PCNA2 complex was then washed off the GST resin and
applied to a Hi-Trap QHP (GE Healthcare) anion exchange
column. The PCNA1–PCNA2–PCNA3 complex was eluted,
and purified to homogeneity, with a linear gradient from
50 to 800 mM NaCl in buffer containing 20 mM Tris–HCl
(pH 8.0) and 1 mM DTT.
FEN1 cell pellets were resuspended in buffer containing
50 mM (N-morhpolino)ethanesulfonic acid (MES) (pH 6.5),
50 mM NaCl, 5 mM MgCl2, 1 mM DTT supplemented with
Complete EDTA-free protease inhibitors. The cells were dis-
rupted by sonication and the bacterial lysate clarified by cen-
trifugation at 48 384 g for 60 min using a Beckman JA-20
rotar. Soluble cell lysate was subsequently incubated at
343 K for 15 min, followed by incubation at 277 K for
10 min to thermoprecipitate host proteins. Precipitated protein
was then removed by centrifugation at 48 384 g for 60 min
using a Beckman JA-20 rotar. Clarified soluble lysate contain-
ing FEN1 from the thermoprecipitation step was then applied
to a Hi-Trap SP (GE Healthcare) cation exchange column and
FEN1 eluted in a linear gradient from 50 to 900 mM NaCl.
Fractions containing recombinant FEN1 were then dialysed
against buffer containing 50 mM MES (pH 6.5), 30 mM
NaCl, 5 mM MgCl2, 1 mM DTT, applied to a Hi-Trap Heparin
HP column (GE Healthcare) and eluted in a linear gradient
from 30 to 700 mM NaCl. Finally, a size exclusion chrom-
atographic step using a 16/60 Superdex S200 column (GE
Healthcare) was employed to purify FEN1 to homogeneity.
Crystallization
Prior to crystallization the PCNA1–PCNA2–PCNA3 complex
was mixed with FEN1 at an equimolar ratio and incubated for
20 min at 294 K. PCNA1–PCNA2–FEN1 co-crystals were
grown by the vapour diffusion method in hanging drops
(space group P212121 a ¼ 93.99 A˚, b ¼ 99.77 A˚, c ¼
99.96 A˚) with one copy of the PCNA1–PCNA2
heterodimer and one copy of FEN1 per asymmetric unit.
PCNA3 was not present in the crystal lattice presumably as
a consequence of the lower binding affinity of this subunit
compared with the PCNA1–PCNA2 heterodimer (13).
Drops were prepared by mixing 100 mM protein complex in
20 mM Tris–HCl (pH 8.0), 200 mM NaCl, 5 mM MgCl2,
2 mM DTT buffer solution with equal volumes of 0.1 M
Acetate (pH 4.8), 8% PEG 8000, 220 mM ZnOAc2 and
30 mM glycyl–glycyl–glycine. Crystals appeared after 48 h,
and took two weeks to reach maximum dimensions of
400 · 300 · 400 mm.
Data collection, model building and refinement
Diffraction data from cryo-cooled native crystals was col-
lected at ID23-1 of the European Synchrotron Radiation
Facility (ESRF) in Grenoble, France at a wavelength of
0.9795 A˚. Images were integrated and scaled using the
programs MOSFLM (16) and SCALA (17). The number of
observed reflections corresponds to a 99.2% complete dataset
to 2.9 A˚ resolution. Molecular replacement was performed
using the PHASER program (18) initially searching for
one copy of FEN1 from Pyrococcus furiosus (19) (PDB
code:1B43) and subsequently for two copies of a human
PCNA monomer (20) (PDB code: 1VYJ). Extensive crystal-
lographic modelling was performed using the program COOT
(21), and crystallographic refinement performed using simu-
lated annealing in the CNS package (22) and TLS/restrained
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refinement using the REFMAC 5 package (23). The refined
model comprises 5708 protein atoms and 81 water molecules
(Table 1). Of the 753 amino acid residues, 98.4% are in
the allowed region of the Ramachandran plot, 1.4% in the
generously allowed region and 0.2% in the disallowed
region. Five regions of FEN1 are disordered in the electron
density map. All figures were prepared using PyMOL (24).
Determination of PCNA heterotrimer chirality by
mutagenesis of the inter-subunit interfaces of
S.solfataricus
Mutations were introduced into the N-terminal (114-YIK-116
to 114-ELE-116) and C-terminal (175-KRY-177 to 175-
EED-177) inter-subunit interfaces of Sso–PCNA1 and the
C-terminal interface of Sso–PCNA2 (E146K, D149K) using
oligonucleotide-mediated site directed mutagenesis. The
mutations were introduced into the pGex4T3–PCNA1
or pGex4T3–PCNA2 construct and recombinant protein
purified as described previously (13). GST pull downs were
performed as described previously (13).
RESULTS
Architecture of the S.solfataricus PCNA1–PCNA2–
FEN1 complex
The PCNA1–PCNA2–FEN1 complex consists of a single
copy of Sso–FEN1 (346 amino acids) bound to Sso–PCNA1
(249 amino acids), which itself forms a heterodimer with
Sso–PCNA2 (246 amino acids)—see Table 1 for crystallo-
graphic statistics. Sso–FEN1 binds via its C-terminus, to
the IDCL segment of Sso–PCNA1, and is orientated, such
that the axis of the DNA-binding groove of Sso–FEN1 (11)
is perpendicular to the plane of the Sso–PCNA1–PCNA2 het-
erodimer partial toroidal ring (Figure 1).
Structure of S.solfataricus FEN1
The structure of the nuclease core domain of S.solfataricus
FEN1 (residues 1–331) closely resembles previously deter-
mined FEN1 structures, consisting of a central six-stranded
b-sheet flanked by a-helices, creating a central groove,
which accommodates the active site residues important for
DNA-binding and phosphodiester backbone cleavage (12,25).
The structure of FEN1 from the archaeon Archaeoglobus
fulgidus, bound to a dsDNA substrate with a single nucleotide
30 flap, has recently been determined (11). Afu–FEN1-bound
to this DNA, which is believed to represent a repair interme-
diate, shows a number of conformational differences from the
apo form of the enzyme. Specifically, the a-4–a-5 region of
Afu-FEN1 becomes ordered to create a helical clamp and the
a-2–a-3 loop undergoes a 5 A˚ shift to create a ‘hydrophobic
wedge’, which packs against the terminal base pair of the
DNA (11). In the PCNA1-bound Sso–FEN1 structure, the
a-4–a-5 region is mostly disordered and the a-2–a-3 loop
is in a conformation expected for the apo form of FEN1.
However, other residues in Sso–FEN1 involved in 30 flap sub-
strate recognition superpose well with the Afu–FEN1–DNA
structure.
Structure of the S.solfataricus PCNA1–PCNA2
heterodimer
Sso–PCNA1 and PCNA2 heterodimerize to form two-thirds
of the classical eukaryotic trimeric PCNA toroidal ring, and
represent the first structure of a PCNA dimer determined to
date. Both Sso–PCNA subunits are composed of two topo-
logically identical N- and C-terminal domains, with each
domain itself consisting of two babbb motifs. In
the Sso–PCNA1–PCNA2 heterodimer, three b-sheets form
the outer surface of the partial ring and support eight a-
helices lining the inside. The N- and C-terminal domains in
each PCNA subunit are then connected by the IDCL, which
lies on the ‘outer’ surface of the partial ring.
The overall architecture and arrangement of secondary
structure elements observed in eukaryote PCNAs, are con-
served in the Sso–PCNA heterodimer; superposition of the
separate human PCNA N- and C-terminal domains (PDB
code: 1VYJ) (20) onto their equivalents in Sso–PCNA1 and
PCNA2 gives r.m.s.d. deviations of 1.89 A˚/1.21 A˚ and
1.06 A˚/1.28 A˚, respectively across 90 equivalent Ca atoms.
However, within this overall structural similarity, the inter-
domain connecting-linker segments that provide the binding
site for PCNA client proteins differ considerably between
the eukaryotic PCNA monomer, and the Sso–PCNA1 and
PCNA2 subunits (see below).
Whilst the Sso–PCNA2 N- and C-terminal domains are
related by the pseudo 2-fold symmetry also observed in
eukaryote PCNA, the N-terminal domain of PCNA1 is
rotated by 3 about an axis perpendicular to the plane of
the partial ring. While we cannot dismiss the possibility
that this is a result of crystal packing interactions, this addi-
tional twist between the domains of Sso–PCNA1 may be
induced by heterodimerization with Sso–PCNA2 and may
Table 1. Data collection and refinement statistics (molecular replacement)
PCNA1–PCNA2–FEN1
Data collection
Space group P212121
Cell dimensions
a, b, c (A˚) 93.99, 99.77, 99.96
Resolution (A˚) 30–2.90 (2.975–2.90)a
Rmerge 0.082 (0.443)
I/ sI 6.9 (1.6)
Completeness (%) 99.2 (99.8)
Redundancy 4.8 (4.9)
Refinement
Resolution (A˚) 30–2.90
No. reflections 20 108
Rwork/Rfree 0.251/0.310
No. atoms
Protein 5708
Ligand/ion 4 Zn2+/3 Mg2+
Water 81
B-factors
Protein 59.7
Ligand/ion 62.7
Water 40.5
R.m.s deviations
Bond lengths (A˚) 0.007
Bond angles (g) 1.026
All diffraction data were collected from one crystal.
aHighest resolution shell data are shown in parentheses
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be a prerequisite for binding Sso–PCNA3, which only occurs
after assembly of a PCNA1–PCNA2 heterodimer (13).
The PCNA1–FEN1 interface
In all structures determined to date involving PCNA or
related clamps, and an interacting client replication or
repair protein, or more commonly a peptide derived thereof,
the interacting segment of the client protein typically adopts
a 310-helical turn and inserts two hydrophobic/aromatic
residues into pockets formed by the outer surface of the
eight-stranded beta sheet and IDCL of the PCNA subunit.
These interactions are furnished by the residues forming the
consensus PIP-box - Qxx(M/L/I)xxF(Y/F) (26), which serves
to anchor the client protein to the clamp. The client poly-
peptide N-terminal of the PIP-box typically makes a short
antiparallel b-zipper interaction with the C-terminal strand
of the clamp subunit, while the client sequence C-terminal
of the 310-helical turn forms an extended beta sheet with
the IDCL (3,27–29).
While the interaction of Sso–FEN1 with Sso–PCNA1
resembles that of the peptide derived from A.fulgidus FEN1-
bound to Afu–PCNA (11), and the human FEN1–PCNA
complex (12), there are distinct differences. Unlike the
human FEN1–PCNA interaction, the PIP-box motif from
Sso–FEN1 is provided by the extreme C-terminal sequence
(339—QTGLDRWF-COOH—346), and thus does not form
an extended b-sheet with the IDCL. However, in an analo-
gous mechanism to the classical PIP-box interaction motif
as seen in the peptide derived from A.fulgidus FEN1-bound
to Afu–PCNA, Phe346 and Trp345 make a double hydropho-
bic ball-and-socket joint with PCNA1 (Figure 2A). Residues
Leu40, Met47, Thr126, Pro128 of PCNA1 and Leu342 of
the PIP-box motif in FEN1 provide the hydrophobic pocket
for Phe346. The hydrophobic pocket for Trp345 is provided
by Pro128, Val130, Leu227, Pro228, Pro247 of PCNA1 and
Thr340, Leu342 of FEN1 and capped by the aliphatic portion
of the Arg344 side chain of FEN1.
The highly conserved Gln339 from the Sso–FEN1 PIP-box
performs an analogous role to the glutamine in the Afu-FEN1
PIP-box derived peptide:PCNA complex (PDB code: 1RXZ)
(11) and makes a water-mediated hydrogen bond to the main-
chain carbonyl of Ala246 in PCNA1. In addition, Sso–FEN1
Gln339 also makes a hydrogen bond to Arg248 of PCNA1.
The intervening residue between Ala246 and Arg248 is a
proline and conserved across the PCNA orthologs. Indeed,
Figure 1. (A) The crystal structure of the Sso–PCNA1:PCNA2:FEN1 complex, determined to 2.9 A˚ resolution. (B) Structure as shown in (A), rotated by
90 about axis as shown. PCNA1, PCNA2 and FEN1 are shown in cartoon representation, coloured blue, olive and purple, respectively. (C) Ca stereo trace
of the PCNA1–PCNA2–FEN1 complex structure, coloured as in (A and B). The inter-domain connecting linkers of the PCNA subunits are shown in red.
The N- and C-terminal residues of each protein are labelled.
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this proline has previously been proposed to act as a rigid
joint at the base of the b-zipper (formed by residues
Gln339–Thr340 of FEN1 and Pro247–Arg248 of PCNA1),
which directs it away from the PCNA surface and prevents
spurious interactions with other PCNA residues (11).
Through hydrogen-bonding to residues on either side of
Pro247 the trajectory of the b-zipper is highly dependent
upon Gln339 in FEN1 and also upon the restricted peptide
conformation backbone of Pro247 itself. However, a number
of other residues play an important role in directing the tra-
jectory of the b-zipper in the Sso–PCNA1–PCNA2–FEN1
structure.
The C-terminal helix (a-12) of Sso–FEN1 makes an extra
turn before the b-zipper in comparison to the human PCNA–
FEN1 structure (PDB code: 1UL1, chain Y). Arg338 of
Sso–FEN1 is situated on this extra turn of the a-12 helix
and forms a hydrogen-bonding network with Glu156 and
the C-terminal oxygen of PCNA1 (Figure 2B). Glu156 is then
poised to form a hydrogen bond with Arg248 of PCNA1 and
contributes towards maintaining the conformation of the
zipper. Thus, the formation of this ‘polar-cap’ on the b-zipper
maintains its trajectory and the resultant position of FEN1
on the PCNA1-2 heterodimer. This additional interaction
between the C-terminus of PCNA1 and FEN1 in comparison
to the human PCNA–FEN1 structure may be required to
compensate for the C-terminal truncation of Sso–FEN1,
which results in loss of the intermolecular b-sheet with the
IDCL of the PCNA subunit (12).
In addition, interaction of residues in the b-3–b-4-
intervening loop of PCNA1 (residues Asp43 and Lys44)
with both the PIP-box motif and the N-terminal region of
FEN1 complete the Sso–PCNA1–FEN1 interface. The side-
chains of Asp43 and Lys44 from PCNA1 form salt bridges
with Lys17 and Asp343 of FEN1, respectively (Figure 2C).
Figure 2. (A) Interaction between the C-terminal PIP-box of Sso–FEN1 (purple) and PCNA1 (shown as electrostatic potential surface). Arrows indicate the
hydrophobic double ball-and-socket joint comprising the terminal Trp345 and Phe346 residues of FEN1. (B) Interaction and hydrogen-bonding network
formation between Arg338 situated on the C-terminus of the a12 helix of Sso–FEN1 with Glu156 and the C-terminal oxygen of PCNA1, 2Fo  Fc electron
density is contoured at 1.5 s. The formation of this ‘polar-cap’ on the b-zipper maintains its trajectory and the resultant position of FEN1 on the PCNA1-2
heterodimer. (C) An additional protein–protein interface involving residues in the b-3–b-4 intervening loop of PCNA1 with both the PIP-box motif and the
N-terminal region of Sso–FEN1 contributes to the resultant conformation of Sso–FEN1 on the PCNA1-2 heterodimer. The side-chains of Asp43 and Lys44 from
PCNA1 form salt bridges with Lys17 and Asp343 of FEN1, respectively.
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Finally, Lys44 makes a main-chain hydrogen bond to Leu342
in the PIP-box motif of FEN1.
The PCNA1–PCNA2 heterodimer interface
Antiparallel interactions between the strands in adjacent
PCNA subunits are the key elements in the intermolecular
PCNA interface and contribute to the formation of three
b-sheets that form a contiguous surface across each inter-
molecular boundary in the ring. In the Sso–PCNA1–PCNA2
interface these intermolecular b-sheets involve b-13 of
PCNA1 and b-9 of PCNA2. However, further interactions
are made between the side-chains of residues participating
in the intermolecular sheet and involve a-3 and a-2 of
PCNA1 and PCNA2 situated on the inside of the ring at
the heterodimer interface. These interactions are responsible
for the specificity of the PCNA subunit interactions, and hence
for the specific chirality of subunit order in the assembly of
the Sso–PCNA heterotrimer.
The b-13, b-9, a-3, a-2 interface produces alternating
buried polar and hydrophobic patches, which determine the
Sso–PCNA subunit specificity. An exceptional feature of
the Sso–PCNA1–PCNA2 interface is the central buried
polar interactions that are mediated by Arg82 and Arg108
on a-2 and b-9 of PCNA2, respectively (Figure 3A). Arg82
makes a hydrogen bond to the main-chain carbonyl of
Val145 of PCNA1 while also making a salt bridge with
Asp149 of PCNA1. Asp149 of PCNA1 then makes a hydro-
gen bond to Tyr177 of PCNA1, thus becoming poised to
make an additional hydrogen bond with Arg108 of PCNA2.
The side chain of Arg108 of PCNA2 is itself held in place
to participate in this interaction with Asp149 through a bifur-
cated hydrogen bond to the main-chain carbonyl of Arg82
of PCNA2. Finally Asp87 of PCNA2 fully satisfies the
hydrogen-bonding potential of Arg108 through a salt bridge
and water-mediated hydrogen bond (Figure 3A).
Extensive hydrophobic interfaces flank the central polar
interactions of PCNA1–PCNA2. On the opposite side of the
PCNA ring to the IDCL these are formed by Leu84, Phe106,
the aliphatic portion of the Arg108 side chain from PCNA2
and Val142, Val145, Ile146 and Leu181 from PCNA1.
On the other side Ile79, Phe110, the aliphatic portion of the
Arg82 side chain of PCNA2 and Val150, Leu152 and
Val153 of PCNA1 form this hydrophobic interface. Finally,
Lys175 at the N-terminal end of b-13 from PCNA1 hydrogen
bonds to Asp75 from the N-terminal end of a-2 from PCNA2
and completes the polar-hydrophobic stripes across the
heterodimeric interface (Figure 3B).
Mutational analysis of S.solfataricus PCNA subunit
interfaces
PCNA has distinct front and back faces, with subunits inter-
acting in a head-to-tail manner. Therefore, the heterotrimeric
ring of S.solfataricus PCNA could adopt one of two con-
formations PCNA1–PCNA2–PCNA3 or PCNA2–PCNA1–
PCNA3. To determine the polarity of the subunits in solution,
and to corroborate the structural data presented here, point
mutations were introduced into the Sso–PCNA1 and Sso–
PCNA2 open reading frame in either the N- or C-terminal
inter-subunit interaction b-strands (b-9 and b-13, respec-
tively). Wild-type and the N- and C-terminally mutated
derivatives (P1N and P1C) of PCNA1, and wild-type and
a C-terminally mutated version of PCNA2 (P2C) were then
made as GST fusion proteins and used in pull-down assays
with the other subunits.
As can be seen in Figure 4, lane 7, and mutation of the Sso–
PCNA1 N-terminal strand of the sequence 114-Tyr-Ile-Lys-
116 to 114-Glu-Leu-Glu-116 (resulting in predicted charge
repulsion to E169 of Sso–PCNA3) abrogated interaction
with Sso–PCNA3 but left Sso–PCNA2 binding essentially
unaltered. Additionally, we mutated the C-terminal–PCNA3
Figure 3. (A) The interface between Sso–PCNA1 and PCNA2. OMIT map electron density is contoured at 1.0 s around residues involved in the buried charged
hydrogen-bonding network at the subunit interface. PCNA1 and PCNA2 are coloured blue and olive, respectively. (B) View as in (A), rotated by 90 about axis
as shown. Electron density has been removed for clarity. In this orientation the hydrophobic residues surrounding the central charged hydrogen-bonding network
are clearly visible.
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interaction—interface of PCNA2 by making the changes
Glu146Lys and Asp149Lys. These mutations abolished
Sso–PCNA3 interaction but left Sso–PCNA2’s interaction
with Sso–PCNA1 unaltered (compare Figure 4, lanes 10
and 12). Thus, these observations are fully consistent with
an arrangement for the heterotrimer in which Sso–PCNA3
interacts with the N-terminal interaction strand of Sso–
PCNA1 and the C-terminal interaction strand of Sso–PCNA2.
Further, mutation of Sso–PCNA1’s C-terminal interaction
strand of the sequence K175-Lys-Arg-Tyr-177 to 175-Glu-
Glu-Asp-177 resulted in loss of both Sso–PCNA2 and
Sso–PCNA3 binding (see Figure 4, lane 17). Taken together,
these data reveal the importance of electrostatic interactions
in defining inter-subunit interactions, support the polarity
of the Sso–PCNA ring indicated by the crystal structure and
confirm that formation of the Sso–PCNA1–PCNA2 hetero-
dimer is an essential prerequisite for recruitment of PCNA3.
DISCUSSION
Specificity of S.solfataricus PCNA heterotrimer
assembly
The crystal structure of the isolated PCNA3 subunit from the
related archaeon Sulfolobus tokodaii, which has 62% identity
to Sso–PCNA3, has recently been determined (PDB code:
1UD9). Sequence threading of the S.solfataricus PCNA3
sequence onto 1UD9 and subsequent superposition of the
N-terminal and C-terminal domains onto the human PCNA
monomer (from 1UL1.pdb) results in an N- and C-domain
root mean square deviation (r.m.s.d.) of 1.30 A˚/1.14 A˚,
respectively across 90 equivalent secondary structure Ca
positions. Thus, a good working model for the full Sso–
PCNA heterotrimer can be constructed.
The structure of the S.solfataricus PCNA1–PCNA2
heterodimer, and the Sso–PCNA1–PCNA2–PCNA3 hetero-
trimer model presented here provide a unique insight into
the molecular specificity of the PCNA heterotrimer assembly.
This specificity is dependent on both surface electrostatic
‘lock-and-key’ complementarity at subunit interfaces and the
pattern of hydrogen-bonding residues presented in the mainly
hydrophobic subunit interface.
Structures of other PCNA and b-clamp rings show a
conserved subunit interface structure, involving formation
of an intermolecular b-sheet and a helix–helix interaction.
In the bacterial b-clamp, the N- and C-terminal regions of
each of the two subunits display marked charge asymmetry,
with the N-terminal interface being mainly positive and the
C-terminal interface mainly negatively charged (30). Four
hydrogen bonds constitute the intermolecular b-sheet and
six ion pairs from residues at the interface surround a small
hydrophobic core. The resultant electrostatic asymmetry
leads to a head-to-tail assembly of the homodimer (29,30).
In human PCNA (31), the intermolecular b-sheet involves
eight hydrogen bonds, but only one ion-pair between differ-
ent subunits, in an otherwise predominantly hydrophobic
interface.
The Sso–PCNA heterotrimer assembly reflects aspects of
both the homotrimeric eukaryotic PCNA, and homodimeric
bacterial b-clamp interfaces; the intermolecular b-sheet
between Sso–PCNA1 and Sso–PCNA2 involves five main-
chain hydrogen bonds and three ion pairs—Asp75, Arg82
and Arg108 of Sso–PCNA2, and Asp149 and Lys175 of
Sso–PCNA1. Inspection of the electrostatic surface potential
of each of these subunit interfaces reveals a striking pattern of
charge complementarity surrounding a ‘C-shaped’ hydro-
phobic core (Figure 5). Furthermore, mutation of both
Lys175 and Arg176 of PCNA1 to glutamate resulting in
charge repulsion disrupts the Sso–PCNA1–PCNA2 interface.
This demonstrates the strong dependence of subunit inter-
actions on these complementary electrostatics.
Comparisons of the electrostatic surface potential of
the Sso–PCNA1 N-terminal domain and the Sso–PCNA2
C-terminal domain with the subunit interfaces of the
Figure 4. Coomassie-stained gels demonstrating the polarity of S.solfataricus PCNA in solution. GST pull downs were performed with 10 mg of GST (lanes 2
and 3), GST-PCNA1 (lanes 4, 5, 14 and 15), GST–PCNA2 (lanes 9 and 10), GST–PCNA1 N-terminal interaction site mutant (lanes 6 and 7, GST-P1N),
GST–PCNA2 C-terminal interaction site mutant (lanes 11 and 12, GST-P2C) or GST–PCNA1-C-terminal interaction site mutant (lanes 16 and 17, GST-P1C)
fusion proteins in the presence (+) or absence () of 10 mg of Sso–PCNA1 and Sso–PCNA3 or Sso–PCNA2 and Sso–PCNA3 as indicated. Lanes 1 and 13 contain
5 mg each of Sso–PCNA2 and Sso–PCNA3, lane 8 has 5 mg each of Sso–PCNA1 and Sso–PCNA3. Because Sso–PCNA2 co-migrates with a breakdown product
of GST-P1 and GST-P1C present in lanes 14–17, the samples were subjected to western blotting using anti- Sso–PCNA2 antisera; the result is shown in the lower
panel.
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Sso–PCNA3 model, show complementary electrostatic pat-
terns, which are non-interchangeable (Figure 5). This electro-
static ‘lock-and-key’ model, which obviates homomeric
interactions by the Sso–PCNA1, Sso–PCNA2 and Sso–
PCNA3 subunits, and mediates a unique and heterotrimeric
arrangement, is supported by the effect of the Lys116Glu
mutation in Sso–PCNA1. This mutation is predicted to dis-
rupt an ion-pair with Glu169 of Sso–PCNA3 and abrogates
the interaction of Sso–PCNA1 with Sso–PCNA3.
S.solfataricus PCNA—client protein specificity
Comparison of human PCNA structures in the presence or
absence of bound client protein/peptide demonstrate little
change in the main-chain conformation of the IDCL as a result
of binding to the PIP-box motif (3,12), suggesting that there
is relatively little induced-fit accompanying client binding.
The structural basis for the selective recruitment of Sso–
FEN1 to Sso–PCNA1 but not the other subunits can thus be
understood by comparison of the binding sites in terms of
the interactions they offer to the specific PIP-box motif of
Sso–FEN1.
When prospective binding of Sso–FEN1 to Sso–PCNA2
is modelled by superimposition of Sso–FEN1–PCNA1 onto
Sso–PCNA2, it is immediately clear that the insertion
of Phe346 into a hydrophobic pocket in Sso–PCNA2, as
observed in the interaction with Sso–PCNA1, is sterically
precluded by a direct clash with Pro123 in the sequence 121-
Gln-Pro-Pro-Ser-124 in the Sso–PCNA2 IDCL (Figure 6C).
The rigid stereochemical constraints imposed across this
region by the double proline, provide the main determinant
for precluding binding (or a conformational change to accom-
modate) Phe346 from Sso–FEN1. Furthermore Glu156,
which participates in the ‘polar-cap’ of the b-zipper for-
med between the PIP-box of Sso–FEN1 and Sso–PCNA1,
is replaced by a valine in PCNA2, adding to the disfavouring
of Sso–FEN1 binding. Finally, the IDCL of PCNA1 adopts
a unique conformation in comparison to all other known
Figure 5. Electrostatic potential surface representations of the interface between the Sso–PCNA1–PCNA2–PCNA3 heterotrimer. NTD and CTD indicate
N-terminal and C-terminal domains, respectively. It should be noted that PCNA3 has been modelled to generate the heterotrimeric PCNA ring. Axes
perpendicular to the plane of the PCNA ring and at the interface between subunits are marked with a white circle. Each PCNA interface has been opened and
rotated by 90 around the axes marked on the heterotrimer to demonstrate the ‘lock-and-key’ electrostatic complementarity between adjacent subunits. Residues
participating in the electrostatic interface that have been mutated are indicated by ‘>’. The C-shaped hydrophobic interface flanked by charged patches on the
PCNA1–PCNA2 interface is labelled.
4522 Nucleic Acids Research, 2006, Vol. 34, No. 16
 at U
niversity of Sussex on June 18, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
PCNA orthologue IDCLs (Figure 6A). This also likely
contributes to the observed client protein specificity between
the S.solfataricus PCNA subunits.
Having elucidated the specificity of Sso–PCNA1 for the
Sso–FEN1 client protein, Sso–PCNA2 was subsequently
analysed for the basis of specificity for binding its client pro-
tein. DNA Polymerase B1 (Sso–Pol B1) has previously been
shown to interact with Sso–PCNA2 through an N-terminal
9 residue PIP-box motif (13), which appears more closely
related to the bacterial b-clamp-binding motif at the sequence
level than to other clamp-binding motifs (Figure 6B) (26).
The structural basis for recognition of this motif has been
revealed by the structure of a complex between the little fin-
ger domain of the translesion DNA polymerase Pol IV/DinB
of E.coli in complex with the b-clamp (29).
Superposition of the b-clamp from this complex (PDB
code: 1UNN) onto Sso–PCNA2 reveals similarities between
elements of the IDCL linker conformation and between
the residues involved in the proposed interaction (see
Figure 6D). In the Ec-Pol IV-b-clamp structure Gln346 of
the Ec-Pol IV consensus sequence binds the b-clamp in
a pocket between the side-chains of His175, Asn320,
Tyr323 and Met364, and a similar pocket also exists in the
Sso–PCNA2 structure for binding of Gln4 of Sso–PolB1.
Finally, the hydrophobic anchor in the C-terminus of the
Ec-Pol IV b-clamp-binding motif is provided by the tri-
peptide sequence Leu-Gly-Leu (29). In Sso–PolB1 the
Leu7-Phe8 dipeptide is in the equivalent position and could
bind in an analogous manner (26).
The classical PIP-box structure forms a 310 helix formed by
residues between the conserved glutamine and the double
aromatic motif. However, the structure of the bacterial
b-clamp-binding consensus motif does not have a helical
segment, presumably because of fewer residues between the
Figure 6. (A) Structural superposition of Sso–PCNA1 (blue) and Sso–PCNA2 (olive) with human PCNA (PDB codes: 1UL1, 1U76, 1VYM), Saccharomyces
cerevisiae PCNA (pdb code: 1PLR) and the model of Sso–PCNA3 (shown in grey). (B) Sequence alignment of observed and postulated PCNA-interacting
motifs from E.coli Polymerase IV and Sso-DNA Polymerase B1. The conserved glutamine is coloured orange. Residues marked in blue and red denote important
clamp-interacting hydrophobic and polar residues, respectively. The structurally equivalent -LeuPhe-/-Leu-Gly-Leu motifs are highlighted by a black box. N- and
C-termini of protein sequences are denoted by *. (C) Structural superposition of Sso–PCNA2 (olive) onto Sso–PCNA1 (blue). The FEN1 C-terminal PIP-box
residues are shown in cartoon representation coloured purple, with the side-chains of residues Trp345 and Phe346 shown as sticks. (D) Structural superposition
of Sso–PCNA2 (olive) and the E.coli b-clamp protein (teal) (PDB code: 1UNN). The b-clamp was co-crystallized with the little finger domain of the DNA
polymerase Pol IV (DinB), the interacting region of which is shown in stick representation.
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conserved glutamine and the hydrophobic anchor. Though
the double proline motif of the Sso–PCNA2 IDCL sterically
precludes Sso–FEN1 PIP-box motif binding, it could how-
ever accommodate a peptide with the same conformation
of Ec-Pol IV. This is demonstrated in the superposition
of Ec-Pol IV peptide onto the Sso–PCNA2 structure
(Figure 6D). Thus, the rigid double Proline motif present in
the IDCL of Sso–PCNA2 plays a dual role in client protein
specificity by sterically precluding Sso–FEN1 binding and
also forming one side of the proposed Sso–PolB1 Leu7-
Phe8 hydrophobic pocket.
The basis of client enzyme–PCNA interaction specificity
in the Sufolobus system appears to reside in the sequence
and structure of the PCNA subunit IDCL, in residues of
PCNA in close proximity to the IDCL and in the client pro-
tein PIP-box sequence and structure. As with the inter-subunit
interactions, the client interactions in the archaeal Sulfolobus
system appear to combine elements of both the eukaryotic
and bacterial PCNA systems.
FEN1 orientation by Sso–PCNA1
Studies of enzyme recruitment to eukaryotic PCNA rings are
complicated by the ability of the homotrimeric clamp to bind
multiple copies of the client. In the crystal structure of the
human PCNA–FEN1 complex, each of the three FEN1 mole-
cules bound to the PCNA ring adopts a different orientation
with respect to its cognate PCNA subunit (Figure 7A–C)
(12), making it very difficult to assign biological significance
to any of those conformations. An important advantage of the
heterotrimeric S.solfataricus PCNA system and its subunit
specificity for client enzymes therefore, is the ability to
Figure 7. (A–C) Superposition of the Sso–PCNA1–FEN1 structure onto chains (A–C) of the human homotrimer suggests a physiologically relevant orientation
of human FEN1 on the human PCNA assembly—(B) (pdb code : 1UL1, chain Y). The human PCNA homotrimer, human FEN1 and superposed Sso–FEN1 are
coloured blue, grey and purple, respectively. (D) Model of DNA-binding to Sso–FEN1 based on superposition with the DNA bound Afu-FEN1 structure. The
black arrows represent the direction of the hand-off of DNA intermediates around the PCNA ring in the sequential repair enzyme cascade mechanism.
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trap, in essence, the correct stoichiometric complex in which
the orientation and conformation of the client enzyme on
the PCNA ring is far more likely to be functionally relevant.
When the Sso–PCNA1 component is used to superimpose
the Sso–PCNA1–FEN1 complex in turn onto the three human
PCNA subunits in the human PCNA–FEN1 structure, one of
the three human FEN1 molecules (chain Y) is found to have
a very similar orientation with respect to its PCNA subunit.
Furthermore, the polypeptide chains containing the PIP-box
motif in both Sso–FEN1 and human FEN1 chain Y have
extremely similar conformations. In both cases, the enzyme
makes additional interactions involving residues outside its
PIP-box motif, with residues in the b-3–b-4 intervening
loop of the associated PCNA subunit, which in combination
with the PIP-box conformation, maintains this orientation
of the FEN1 core with respect to the PCNA ring.
That the same FEN1–PCNA interaction and orientation is
seen in proteins from two highly diverged species, and in the
presence of very different crystal environments, suggests
strongly that this is a biologically significant conformation.
To gain further insight into this, we superimposed the
FEN1 component of the Afu-FEN1–DNA complex onto
the PCNA-bound Sso–FEN1, to model a fully assembled
DNA bound Sso–FEN1–PCNA1–PCNA2–PCNA3 complex
(Figure 7B). Superposition of residues involved in the
30 flap substrate recognition results in a r.m.s.d. of 1.12 A˚
across 58 equivalent Ca positions in respect to A.fulgidus
DNA bound FEN1. The low r.m.s.d. across this region
demonstrates the conservation of the 30-flap binding mode
in the archaeal class of FEN1 enzymes. As can be seen, the
double-stranded portion of the 30-flap DNA substrate bound
to FEN1 is positioned such that it could pass through
the lumen of the Sso–PCNA ring, suggesting that we have
crystallized a physiologically relevant orientation of FEN1
on PCNA, in which it is positioned for productive interaction
with a DNA substrate encircled by the PCNA ring. We note
however, that the helical axis of the double-stranded segment
of the FEN1-bound DNA is not perpendicular to the PCNA
ring, but is tilted by 30. Although this complex is a
model and changes in the conformation of the DNA and
adaptor proteins may occur, it does suggest that the common
assumption of DNA passing perpendicularly through toroidal
clamps, without direct contact, may not be the case, espe-
cially when the DNA is engaged by a PCNA client enzyme.
PCNA coordination and orientation of enzyme cascades
The specificity of the Sso–PCNA heterotrimer subunits for
their respective client proteins as demonstrated in this study,
and previously (13), permits assignment of the chirality of the
sequential enzyme cascade in the base excision repair and
replication pathways as previously postulated (see Figure 7D)
(11,27). Sequential action of a DNA polymerase, a 50-flap
endonuclease and a DNA ligase can achieve error-free ‘long-
patch’ repair of a single-strand DNA gap generated by, e.g.
base excision by a glycosylase and AP-endonuclease (7).
A uracil-DNA glycosylase (Sso-UDG1) has recently been
characterized in S.solfataricus and shown to interact with
Sso–PCNA3 (15). The arrival of a DNA glycosylase at the site
of a lesion is the initiating step in the base excision repair
pathway (32). After cleavage of the N-glycosidic bond, the
AP site is removed by an AP-endonuclease, and the resulting
single-strand gapped DNA passed to Sso-DNA polymerase
B1, which is specific for binding to Sso–PCNA2 and
performs displacement synthesis across the gap. Next, Sso–
FEN1-bound to Sso–PCNA1, loads from the 50 end of the
flap and tracks back to the 50-flap—duplex DNA junction
(33). After removal of the flap, Sso-DNA ligase bound to
Sso–PCNA3 completes the repair process through ligation
of the nick (Figure 7D). It is of particular interest that the
client enzymes for the first (UDG) and final (DNA ligase)
step of the pathway bind the same PCNA subunit, thereby
allowing time for client enzyme exchange on the PCNA
ring during the intermediary steps of the repair pathway cas-
cade. Thus, as the heterotrimeric PCNA rotates around the
double helix, and translates back and forth along it, DNA
repair and replication intermediates can be passed to the
next client repair enzyme in a highly co-ordinated and regu-
lated manner.
S.solfataricus has evolved three different PCNA subunits
to control the correct assembly of client enzymes on the
PCNA ring, and help select meaningful combinations from
the plethora of possibilities. Eukaryotes also possess a het-
rotrimeric system in addition to homotrimeric PCNA, formed
by the Rad9, Rad1 and Hus1 proteins (34,35). While this
so-called 9-1-1 complex is involved in specialized DNA
damage signalling roles, including facilitation of the ATR-
dependent phosphorylation and activation of Chk1 (36), it
also appears to recapitulate many of the DNA repair enzyme
recruitment activities of PCNA (37). However, unlike the
Sulfolobus heterotrimeric PCNA, the individual subunits of
9-1-1 do not seem to have discriminatory binding sites, so
that MYH, DNA Lig1, FEN1 and Polb all appear to bind
equally well to all three subunits (38–42). Despite the lack
of an enzyme-selective clamp, as in Sulfolobus, higher
eukaryotes are nonetheless presented with the same problem
and have likely evolved an alternative mechanism for
coordinating pathway assembly, although the nature of this
is not yet clear. One possibility is that meaningful combina-
tions are selected by specific lateral contacts between client
enzymes attached to adjacent subunits, however further
work will be required to test this hypothesis.
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